Proactive Health Intervention for Tobacco Users (Get PHIT)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

536 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-02-28

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to understand how information about smokers' health risks affects their attitudes, mood, and behavior.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dissemination of Tobacco Tactics for Hospitalized Smokers

NCT01309217

Smoking Cessation

COMPLETED PHASE4

Identifying Optimal Smoking Cessation Intervention Components (Cessation)

NCT01116986

Smoking Smoking Cessation Nicotine Dependence

COMPLETED PHASE4

Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit

NCT02905656

Smoking Cessation

COMPLETED NA

Engagement With an Adaptive Mobile Health Smoking Cessation Intervention

NCT04020718

Tobacco Use Cessation

COMPLETED PHASE4

Cognitive Behavioral Treatment with Activity Trackers for Smoking Cessation

NCT06629467

Tobacco Use Cessation Physical Activity

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current study will test a community-based, tobacco intervention. The project will compare the effects of a proactive, personally-tailored, biologically-based motivational intervention to those of a proactive, generic motivational intervention for smoking cessation. The biologically-based motivational treatment will include feedback on participants' carbon monoxide (CO) exposure (expired CO and estimated carboxyhemoglobin levels), pulmonary functioning assessed via spirometry, and self-reported smoking-related symptoms. All participants will be given equal access to action-oriented treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Intervention

Group Type EXPERIMENTAL

motivational counseling

Intervention Type BEHAVIORAL

behavioral motivational counselling

2

Control

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

motivational counseling

behavioral motivational counselling

Intervention Type BEHAVIORAL

placebo

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old,
* smoke greater than or equal to 15 cigarettes a day,
* have an expired CO level greater than or equal to 10 ppm,
* are not currently being treated for smoking cessation,
* can read and write in English,
* provide contact information,
* agree to the study requirements,
* have no medical contraindications for spirometry assessment,
* and no an obvious cognitive or physical impairment that would preclude their ability to comprehend or fully participate in the study.